Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor α-blocking agent:: Comment on the article by Pisetsky and the letter from Aringer et al

被引：32

作者：

Fautrel, B ^{[1
]}

Foltz, V ^{[1
]}

Frances, C ^{[1
]}

Bourgeois, P ^{[1
]}

Rozenberg, S ^{[1
]}

机构：

[1] Grp Hosp Pitie Salpetriere, F-75634 Paris, France

来源：

ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 05期

关键词：

D O I：

10.1002/art.10271

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1408 / 1409

页数：2

共 14 条

[1]

Aringer M, 2001, ARTHRITIS RHEUM, V44, P1721, DOI 10.1002/1529-0131(200107)44:7<1721::AID-ART302>3.0.CO

[2]

2-J

[3] Thalidomide: Current and potential clinical applications [J].

Calabrese, L ;

Fleischer, AB .

AMERICAN JOURNAL OF MEDICINE, 2000, 108 (06) :487-495

[4]

Charles PJ, 2000, ARTHRITIS RHEUM, V43, P2383, DOI 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO

[5]

2-D

[6] Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: Diagnostic criteria and therapeutic implications [J].

Chlebus, E ;

Wolska, H ;

Blaszczyk, M ;

Jablonska, S .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (03) :405-412

[7] THALIDOMIDE IN THE TREATMENT OF 60 CASES OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS [J].

KNOP, J ;

BONSMANN, G ;

HAPPLE, R ;

LUDOLPH, A ;

MATZ, DR ;

MIFSUD, EJ ;

MACHER, E .

BRITISH JOURNAL OF DERMATOLOGY, 1983, 108 (04) :461-466

[8] Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus - A review by the Italian Group of Immunodermatology [J].

Parodi, A ;

Caproni, M ;

Cardinali, C ;

Bernacchi, E ;

Fuligni, A ;

De Panfilis, G ;

Zane, C ;

Papini, M ;

Veller, FC ;

Vaccaro, M ;

Fabbri, P .

DERMATOLOGY, 2000, 200 (01) :6-10

[9]

Pisetsky DS, 2000, ARTHRITIS RHEUM, V43, P2381, DOI 10.1002/1529-0131(200011)43:11<2381::AID-ANR1>3.0.CO

[10]

2-M

← 1 2 →